Phases Analysis
What is Phases?
Phases deploys AI agents to oversee clinical trials, with a homepage headline describing automated clinical trial oversight and execution. The product monitors trial operations in real time, detects risks, and takes autonomous actions across connected systems. The site highlights clinical-trial workflow coverage, audit readiness, and compliance controls for regulated research environments.
Location
San Francisco, United States
Employees
1-10
Founded
2025
Industry
Healthcare, Healthcare It
AI Category
AI-native
YC Batch
S25
YC Partner
Gustaf Alstromer
Who are the founders of Phases
JW
James Wall
Co-founder & CEO
AZ
Anton Zaliznyi
Co-founder & Chief AI Officer
JV
Jonathan van Wersch
Co-founder & CTO
Product Description
Phases specializes in automating clinical trial recruitment through its AI agent named Polly. The main product offerings include:
-
Polly: An AI solution that automates patient recruitment for clinical trials.
- Key Features:
- Speed: Reduces the time for screening conversations from over 30 minutes to just 1 minute.
- Scale & Flexibility: Engages patients 24/7, capable of handling thousands of conversations simultaneously.
- Cost Efficiency: Automates labor-intensive recruitment tasks, allowing trials to be filled faster and at a lower cost.
- Key Features:
-
Integration: The solution integrates seamlessly into existing workflows, eliminating the need for new tools or extensive training.
-
Enhanced Engagement: By automating communication, Polly improves participant engagement, transforming the overall clinical trial operations.
Phases aims to streamline the recruitment process, making it more efficient for clinical trial teams and healthcare organizations.
See something that needs updating? Suggest edits to this profile.